News | September 25, 2025
Evonik launches MaxiPure Polysorbate 80 for injectable drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
A key highlight will be Brenntag’s qualified amino acids portfolio
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
